31 Jul, 2026 3:53 PM (IST)
Procter & Gamble Hygiene & Healthcare Performance
- Today's Low
- ₹8,419
- Today's High
- ₹8,620
- 52 Week Low
- ₹8,419
- 52 Week High
- ₹14,509
- Open Price₹8,519
- Previous Close₹8,477
- Volume20,028
- 50 DMA₹9,115.40
- 100 DMA₹9,693.30
- 200 DMA₹10,729.20
Procter & Gamble Hygiene & Healthcare Chart
Investment Returns
- Over 1 Month -4.07%
- Over 3 Month -15.3%
- Over 6 Month -27.91%
- Over 1 Year -37.24%
Smart Investing Starts Here Start SIP with Procter & Gamble Hygiene & Healthcare for Steady Growth!
Procter & Gamble Hygiene & Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 35.3
- PEG Ratio
- -7.7
- Market Cap Cr
- 27,897
- P/B Ratio
- 37
- Average True Range
- 182.6
- EPS
- 243.6
- Dividend Yield
- 3
- MACD Signal
- -110.4
- RSI
- 37.23
- MFI
- 26.47
Latest Stock News Updates
<h3><span style="font-size:16px;"><strong>Personal Products company Procter & Gamble Hygiene & Healthcare announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c2348603712="">Total Income for Q1FY27 stood at Rs 90,089 lakh, representing a YoY decline of 4.64% from Rs 94,472 lakh in Q1FY26 and a QoQ decrease of 5.55% from Rs 95,379 lakh in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Revenue from Operations in Q1FY27 was Rs 89,146 lakh, reflecting a YoY decrease of 4.86% compared to Rs 93,703 lakh in Q1FY26 and a QoQ decline of 5.30% from Rs 94,132 lakh in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Profit Before Tax (PBT) for Q1FY27 was reported at Rs 16,963 lakh, down 35.92% YoY from Rs 26,470 lakh in Q1FY26 and down 22.23% QoQ from Rs 21,811 lakh in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Net Profit for the period reached Rs 12,627 lakh in Q1FY27, showing a YoY decline of 34.25% from Rs 19,206 lakh in Q1FY26 and a QoQ decrease of 17.54% from Rs 15,313 lakh in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Total Comprehensive Income for Q1FY27 was Rs 12,734 lakh, marking a 33.08% YoY decrease from Rs 19,029 lakh in Q1FY26 and a 17.21% QoQ decline from Rs 15,382 lakh in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Earnings Per Share (EPS) (Basic & Diluted) for Q1FY27 stood at Rs 38.90, compared to Rs 59.17 in Q1FY26 and Rs 47.17 in Q4FY26.</li> <li _ngcontent-ng-c2348603712="">Other Income for Q1FY27 was Rs 943 lakh, an increase from Rs 769 lakh in Q1FY26, but a decline from Rs 1,247 lakh in Q4FY26.</li> </ul> <p _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Segment Performance:</strong> The Company has two primary operating segments: Health Care Products (comprising ointments, creams, cough drops, and tablets) and Hygiene Products (comprising feminine hygiene products and other skin care hygiene).</li> <li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Single Reportable Segment:</strong> These individual operating segments have been aggregated into a single primary reportable segment—manufacturing, trading, and marketing of Health and Hygiene Products—in accordance with Ind AS 108.</li> <li _ngcontent-ng-c2348603712=""><strong _ngcontent-ng-c2348603712="">Operational Structure:</strong> The Company confirmed that it does not have any subsidiary, associate, or joint venture as of June 30, 2026.</li> </ul> <p><strong>Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care, said:</strong> “We continue to invest strategically behind our brands, innovation and market capabilities, even as the geopolitical environment remains challenging. Our confidence in the Integrated Growth Strategy - focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and value), productivity, constructive disruption, and an agile and accountable organization; remains unwavering, and we believe the continued execution of this strategy will strengthen our business, unlock future growth opportunities and build an even stronger company for the future.”</p> <p><a class="lb" href="/get-document/post/pdf/5752669/" target="_blank">Result PDF</a></p>
- Trendlyne
- 4 days 13 hours ago
Company has informed the exchange about the unaudited financial results for the quarter ended June 30, 2026
- BSE India
- 4 days 14 hours ago
Company has informed the exchange about the press release for the quarter ended on June 30, 2026
- BSE India
- 4 days 14 hours ago
Procter & Gamble Hygiene & Healthcare Financials
Procter & Gamble Hygiene & Healthcare Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹8,840.10
- 50 Day
- ₹9,115.40
- 100 Day
- ₹9,693.30
- 200 Day
- ₹10,729.20
Resistance and Support
- R3 8,869.80
- R2 8,744.70
- R1 8,669.30
- S1 8,468.80
- S2 8,343.70
- S3 8,268.30
Procter & Gamble Hygiene & Healthcare Corporate Actions - Bonus, Splits, Dividends
About Procter & Gamble Hygiene & Healthcare
Procter & Gamble Hygiene and Healthcare Ltd. is a subsidiary of Procter & Gamble (P&G). They are one of India's fastest-growing FMCG companies with a portfolio of brands such as Vicks & Whisper.
Vicks has been India's leading over-the-counter (OTC) Cough and Cold Brand since its launch in 1952. The products under this brand include Vicks Action500+, Vicks VapoRub, Vicks Cough Drops, Vicks Formula 44 Cough Syrup and Vicks Inhaler.
Whisper is another top feminine hygiene brand with a product portfolio consisting of Whisper Maxi Regular, Whisper Maxi XL Wings, Whisper Ultra with Wings and Whisper Choice.
It’s manufacturing facilities are located in Goa and Baddi in Himachal Pradesh, apart from it the company also has third-party manufacturing plants across India.
Business Verticals
P&G Hygiene and Healthcare Ltd. is engaged in manufacturing, distributing and selling personal health care products. It operates primarily in two segments: Feminine Care Business (Whisper) and Health Care Business (Vicks).
Whisper continues to be the market leader in the feminine care business. The "Comfort & Soft" segment, with the launch of Whisper Choice Aloe Vera's longer length, and the upgrade of their flagship Ultra and Choice portfolio, have transcended customer experience.
In the healthcare business, Procter & Gamble Hygiene and Healthcare Ltd. continued to win despite the challenges due to COVID-19 with the growth of Vicks' portfolio. Vicks 3-in-1 throat lozenges boosted the growth of this segment due to increased demand with world-class communication across all our sub-brands and superior go-to-market strategy.
Milestones
1964 - On July 20, the Company was incorporated in Mumbai.
1979 - The premier product of the company Vicks Action 500 was launched
1985 -
In September, the Company's herbal plant in Annaram, Andhra Pradesh's Medak district, was commissioned to produce herbal and other natural ingredient products.
Procter & Gamble Co. acquired Richardson-Vicks Inc. in October, and as a result, Richardson Hindustan Ltd. (RHL) became a Procter & Gamble Co. affiliate. Thus, the name of the Company was changed from Richardson Hindustan Ltd. to Procter & Gamble India Ltd. on April 4, 1988.
1992 - The Company introduced Whisper Extra long and Whisper Extra Large.
1993 - The Company High-Quality Whisper with Wings was introduced.
1995 -
Vicks Vitamin 'C' is a premium line of drops introduced by the Company.
Whisper Extra Dry, a high-performance sanitary protection product, was introduced by the Company.
The Company ventured to set up a state-of-the-art technology healthcare plant in Goa.
1996 - The Company introduced a test market for Vicks Vaporub Super Balm.
1998 - Procter & Gamble India Ltd. has now become Procter & Gamble Hygiene and Health Care Ltd.
2000 -
The Company introduced a new brand, Tampax, to the Indian Sanitary napkin market.
Vicks cough drop was reintroduced in a new 2.5 gm blue back.
Vicks Plus medicated lozenges made their way in India.
Gary W. Cofer, country manager, Procter and Gamble, India, is the new managing director of Procter and Gamble Hygiene and Healthcare Ltd. w.e.f. September 1.
Doctoranywhere.com and Procter & Gamble Hygiene & Healthcare join hands.
Vicks Action 5000 was reintroduced in an attractive Blue international pack.
2001 -
The Company launched a Whisper Ultra Day-Night pack for the first time in Tamil Nadu, India.
They kickstarted an outdoor advertising campaign for Vicks Plus medicated lozenges.
2002 - P&G Hygiene and Health Care Ltd. announced that Mr. Gary Cofer would step down as Managing Director on April 1, 2002. Mr. Shantanu Khosla will be named Managing Director.
2003 - The Company launched a new VICKS Formula 44 cough syrup.
2004 - 'Whisper Choice' makes its entry in Tamil Nadu, Andhra Pradesh, Kerala and Karnataka with a pack of 10 pads priced at Rs 26 as a test market launch.
2019 - The Company was awarded the Packaging Innovation Awards 2019 and Best Workplaces for Innovators 2019.
2020 - The Company was awarded Top 25 Most Innovative Client Companies 2020.
View More- NSE Symbol
- PGHH
- BSE Symbol
- 500459
- ISIN
- INE179A01014
Similar Stocks to Procter & Gamble Hygiene & Healthcare
Popular Stocks
Procter & Gamble Hygiene & Healthcare FAQs
Procter & Gamble Hygiene & Healthcare share price is ₹8,594 As on 03 August, 2026 | 03:00
The Market Cap of Procter & Gamble Hygiene & Healthcare is ₹27896.7 Cr As on 03 August, 2026 | 03:00
The P/E ratio of Procter & Gamble Hygiene & Healthcare is 35.3 As on 03 August, 2026 | 03:00
The PB ratio of Procter & Gamble Hygiene & Healthcare is 37 As on 03 August, 2026 | 03:00
The 52 week High & Low of Procter & Gamble Hygiene & Healthcare is ₹14509/₹8419 respectively As on 03 August, 2026 | 03:00
Procter & Gamble Hygiene and Health Care Ltd. recorded net sales of INR 3574 as of Jun 21, 2022.
Procter & Gamble Hygiene and Healthcare Ltd. stock is an excellent long-term (1-year) investment with an expected long-term increase in the price.
The Company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.